Metabolic profiling using Seahorse analysis showed that CCR5 inhibition reduced oxygen consumption rate (OCR) in a dose-dependent manner, consistent with modulation of glycolytic and metabolic ...
Srinagar: The Department of Biochemistry, University of Kashmir (KU), is set to host the 45th Annual Meeting of the Indian ...
Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue. A new “Tumor Activated Therapy™” in development at the small ...
Despite substantial progress in cancer treatment, durable benefit is still frequently limited by the ability of tumors to adapt under therapeutic pressure.
In the field of neuro-oncology, the dual topics of cellular metabolism and the tumor microenvironment (TME) have gained ...
Real-world analyses to evaluate the role of TIGIT as a target in first-line (1L) gastric, gastroesophageal junction, and esophageal adenocarcinomas (GC/GEJC/EAC). This is an ASCO Meeting Abstract from ...
An exploratory clinical study investigating the neoadjuvant treatment of HER2-low expressing, stage II-III breast cancer with disitamab vedotin combined with penpulimab (RCVDBCIIR005). This is an ASCO ...
The tumor microenvironment is not just a site of cancer growth—it is a high-stakes metabolic contest where tumor and immune cells vie for limited resources. Amino acids, once seen as passive nutrients ...
Tumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can be ...
Over the past decade, the advent of immune checkpoint blockade (ICB) therapy has transformed cancer treatment. Unlike conventional cytotoxic and targeted therapies, immunotherapy leverages both the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results